The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
Open accessAbstract
The TOR (target of rapamycin) kinase limits longevity by poorly understood mechanisms. Rapamycin suppresses the mammalian TORC1 complex, which regulates translation, and extends lifespan in diverse species, including mice. We show that rapamycin selectively blunts the pro-inflammatory phenotype of senescent cells. Cellular senescence suppresses cancer by preventing cell proliferation. However, as senescent cells accumulate with age, the senescence-associated secretory phenotype (SASP) can disrupt tissues and contribute to age-related pathologies, including cancer. MTOR inhibition suppressed the secretion of inflammatory cytokines by senescent cells. Rapamycin reduced IL6 and other cytokine mRNA levels, but selectively suppressed translation of the membrane-bound cytokine IL1A. Reduced IL1A diminished NF-κB transcriptional activity, which controls much of the SASP; exogenous IL1A restored IL6 secretion to rapamycin-treated cells. Importantly, rapamycin suppressed the ability of senescent fibroblasts to stimulate prostate tumour growth in mice. Thus, rapamycin might ameliorate age-related pathologies, including late-life cancer, by suppressing senescence-associated inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the secretome of senescent tumor cells can also drive tumor progression by promoting inflammation and potentially stimulating the growth and invasiveness of nearby tumor cells [148,154,163].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [163]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The NF- κB, p38, mTOR and C/EBPβ signalling pathways are major components of the SASP 63-67 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Rapamycin, an immunosuppressant, decreases the SASP and maintains cell cycle arrest but does not kill Sncs (24).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment with rapamycin (and its analogue RAD001)232 attenuated the protumorigenic SASP230, prevented senescence233, impaired SASP-mediated immune recognition of oncogene-expressing cells and ameliorated liver dysfunction in naturally aged mice231.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [231]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the nutrient sensing pathways, mTOR and NAD, are involved in SASP regulation.56, 57, 58”
From Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer (2020) · cites this paper as [56]
The cited source says what the claim attributes to it.
In the citing paper
“In various preclinical studies, the mTOR inhibitor rapamycin might have the context-dependent potential to induce senescence 45 , diminish NF-κB activity 65,66 , suppress the pro-inflammatory SASP at the translational level, and limit the growth-promoting effect of senescent bystander fibroblasts on prostate tumours 66 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [66]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and the serine/threonine kinase MK2, which indirectly stabilizes many cytokine-encoding transcripts231.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [231]
Experimental — accuracy not yet measuredIn the citing paper
“It also differentially regulates translation of IL-1A, the master regulator of SASP that subsequently engages IL-6/IL-8 (Orjalo et al., 2009; Laberge et al., 2015) and MAP kinase-activated protein kinase 2 (MAPKAP2) through 4EBP1, a translation repressor protein (Herranz et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Laberge et al., 2015
In the citing paper
“Inhibition of mTOR by rapamycin suppresses the secretion of inflammatory cytokines by senescent cells (Herranz et al., 2015; Laberge et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Laberge et al., 2015
In the citing paper
“IL-1α is the key driver of the SASP 79,80 , with upstream expression controlled in part by ATM/ATRmediated liberation of GATA4 from p62-directed autophagy 81 and/or an mTORC1-dependent pathway 82 .”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [82]
In the citing paper
“As an alternative approach, reduction of the SASP through “senostatic” or “senomorphic” approaches may be less toxic and has been shown to be effective in animal models (Birch and Passos, 2017; Georgilis et al., 2018; Laberge et al., 2015; Laberge et al., 2012; Niedernhofer and Robbins, 2018; Xu et al., 2015; Yoshimoto et al., 2013).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Laberge et al., 2015
In the citing paper
“Hypoxia impairs mammalian target of rapamycin (mTOR) activity, leading to reduced IL-1α translation to support NF-κB activity and SASP induction [162,163].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [163]
In the citing paper
“The increase in mTORC1 activity is essential for implementing the SASP by modulating the translation of IL-1α and MAP kinase-activated protein kinase 2 (MAPKAPK2) [162,163].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [163]
In the citing paper
“SASP inhibition by the mTOR inhibitor rapamycin can suppress the capacity of senescent fibroblasts to stimulate prostate tumor growth in mice [163].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [163]
In the citing paper
“inhibition of mTOR by rapamycin selectively inhibits the SASP and SA β‐gal staining of senescent cells without affecting their cell cycle arrest”
From Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism (2017) · cites this paper as Laberge et al., 2015
In the citing paper
“Rapamycin treatment suppressed SA-βgal activity (~ 50%) in irradiated cells (Fig. 5H), as expected [68]”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [68]
In the citing paper
“The mTOR pathway is a negative regulator of autophagy and is implicated in cellular senescence [67], most notably through SA-βgal activity and the expression of p16 and p21 markers [67], [68].”
From Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis (2018) · cites this paper as [68]
In the citing paper
“These factors are commonly described as the mediator of the pro-disease functions of senescent cells in vivo59.”
From Algorithmic assessment of cellular senescence in experimental and clinical specimens (2021) · cites this paper as [59]
In the citing paper
“These in vitro observations have been further substantiated in vivo, where co-injection of senescent fibroblasts has been shown to increase tumourigenicity in xenograft models, including primary breast cancer tissues.26,45–47”
From Paracrine roles of cellular senescence in promoting tumourigenesis (2018) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Self-citationCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Self-citationRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Self-citationClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1782 · Cited by 2,299
Cited by
Sorted by citations
Items 501–600 of 998
Miao, P., Yang, D., Chen, X., Guo, Z., & Tang, Y. (2017) · Microchimica Acta · doi:10.1007/s00604-017-2419-5 · Cited by 34
Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway
Kochetkova, E. Y., Blinova, G. I., Bystrova, O. A., Martynova, M. G., Pospelov, V. A., & Pospelova, T. V. (2017) · Aging · doi:10.18632/aging.101325 · Cited by 34
Effects of cellular senescence on metabolic pathways in non-immune and immune cells
Frasca, D., Saada, Y. B., Garcia, D., & Friguet, B. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111428 · Cited by 35
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
Netti, G. S., Franzin, R., Stasi, A., Spadaccino, F., Strologo, A. D., Infante, B., Gesualdo, L., Castellano, G., Ranieri, E., & Stallone, G. (2021) · Cells · doi:10.3390/cells10092426 · Cited by 34
Wang, C., Long, Q., Fu, Q., Xu, Q., Fu, D., Li, Y., Gao, L., Guo, J., Zhang, X., Lam, E. W. ‐., et al. (2021) · Oncogene · doi:10.1038/s41388-022-02476-7 · Cited by 37
Self-citationSenescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 37
The Role of Molecular and Cellular Aging Pathways on Age-Related Hearing Loss
Ege, T., Tao, L., & North, B. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179705 · Cited by 39
He, Y., Peng, X., Wu, T., Yang, W., Liu, W., Zhang, J., Su, Y., Kong, F., Dou, X., & Li, J. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.168 · Cited by 33
Cho, S., Kim, A. Y., Kim, J., Choi, D. H., Son, E., & Shin, D. W. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17824 · Cited by 35
Braun, J. A., Herrmann, A. L., Blase, J. I., Frensemeier, K., Bulkescher, J., Scheffner, M., Galy, B., Hoppe‐Seyler, K., & Hoppe‐Seyler, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.32709 · Cited by 33
Cellular Senescence Triggers Altered Circadian Clocks With a Prolonged Period and Delayed Phases
Ahmed, R., Nakahata, Y., Shinohara, K., & Bessho, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.638122 · Cited by 32
Autophagy and senescence in cancer therapy
Patel, N. H., Bloukh, S., Alwohosh, E., Alhesa, A., Saleh, T., & Gewirtz, D. A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.002 · Cited by 36
Wang, W., Chen, X., & Cai, G. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111403 · Cited by 36
Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 36
Su, H., Waldron, R. T., Gong, R., Ramanujan, V. K., Pandol, S. J., & Lugea, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148999 · Cited by 33
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Nelke, C., Schroeter, C. B., Theissen, L., Preuße, C., Pawlitzki, M., Räuber, S. J., Dobelmann, V., Cengiz, D., Kleefeld, F., Roos, A., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02637-2 · Cited by 33
Branched‐Chain Amino Acid Accumulation Fuels the Senescence‐Associated Secretory Phenotype
Liang, Y., Pan, C. C., Yin, T., Wang, L., Gao, X., Wang, E., Quang, H., Huang, D., Tan, L., Xiang, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202303489 · Cited by 35
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
Wan, R., Wang, L., Zhu, M., Li, W., Duan, Y., & Yu, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216410 · Cited by 34
Targeting senescent cells for the treatment of age-associated diseases
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae091 · Cited by 38
Maciel-Barón, L. Á., Morales-Rosales, S. L., Silva‐Palacios, A., Rodríguez‐Barrera, R., García, J. A., Luna‐López, A., Pérez, V., Torres, C. A., & Königsberg, M. (2018) · Biogerontology · doi:10.1007/s10522-018-9767-3 · Cited by 32
Loss of RNA-binding protein GRSF1 activates mTOR to elicit a proinflammatory transcriptional program
Noh, J. H., Kim, K. M., Pandey, P. R., Hooten, N. N., Munk, R. B., Kundu, G., De, S., Martindale, J. L., Yang, X., Evans, M. K., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz082 · Cited by 33
Antonioli, E., Torres, N., Ferretti, M., Piccinato, C. D. A., & Sertie, A. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0204784 · Cited by 35
Ilie, O., Ciobica, A. S., Riga, S., Dhunna, N., McKenna, J., Mavroudis, I. A., Doroftei, B., Ciobanu, A. M., & Riga, D. (2020) · Medicina · doi:10.3390/medicina56110626 · Cited by 34
Cai, Z., Zhang, Y., Liu, S., & Liu, X. (2022) · The American Journal of Sports Medicine · doi:10.1177/03635465221098133 · Cited by 32
Self-citationMesenchymal stromal cell senescence in haematological malignancies
Plakhova, N., Panagopoulos, V., Vandyke, K., Zannettino, A. C. W., & Mrozik, K. M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10069-9 · Cited by 33
Translating the effects of mTOR on secretory senescence
Tomimatsu, K., & Narita, M. (2015) · Nature Cell Biology · doi:10.1038/ncb3244 · Cited by 33
Telomeres: beacons of autocrine and paracrine DNA damage during skin aging
Victorelli, S. G., & Passos, J. F. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1728016 · Cited by 35
Roth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2023) · Allergy · doi:10.1111/all.15977 · Cited by 31
Wang, P., Konja, D., Singh, S., Zhang, B., & Wang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041978 · Cited by 37
Senescence and SASP Are Potential Therapeutic Targets for Ischemic Stroke
Ouvrier, B., Ismael, S., & Bix, G. J. (2024) · Pharmaceuticals · doi:10.3390/ph17030312 · Cited by 32
A nutrigeroscience approach: Dietary macronutrients and cellular senescence
Calubag, M. F., Robbins, P. D., & Lamming, D. W. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.025 · Cited by 33
Interleukin-1α as an intracellular alarmin in cancer biology
Voronov, E., Dinarello, C. A., & Apte, R. N. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.006 · Cited by 33
Goligorsky, M. S. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.01.016 · Cited by 32
Liu, H., Huang, B., Xue, S., Kin Pong, U., Tsang, L. L., Zhang, X., Li, G., & Jiang, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01798-1 · Cited by 31
Ribosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
Gallage, S., Irvine, E. E., Pedroni, S. M. A., Barragan Avila, J. E., Khadayate, S., Pombo, J., Brookes, S., Heide, D., Dharmalingham, G., Choudhury, A. I., et al. (2023) · doi:10.1101/2023.10.17.562098 · Cited by 31
Ullah, A., Chen, Y., Singla, R. K., Cao, D., & Shen, B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107213 · Cited by 31
Inflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?
Cătană, C.-S., Călin, G. A., & Berindan‐Neagoe, I. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00085 · Cited by 31
Gao, L., Slack, M. A., McDavid, A., Anolik, J. H., & Looney, R. J. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0800-6 · Cited by 29
Odeh, A., Dronina, M. A., Domankevich, V., Shams, I., & Manov, I. (2019) · Aging Cell · doi:10.1111/acel.13045 · Cited by 29
Sieben, C. J., Jeganathan, K. B., Nelson, G. G., Sturmlechner, I., Zhang, C., van Deursen, W. H., Bakker, B., Foijer, F., Li, H., Baker, D. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126863 · Cited by 30
Promises and challenges of senolytics in skin regeneration, pathology and ageing
Pils, V., Ring, N., Valdivieso, K., Lämmermann, I., Грубер, Ф., Schosserer, M., Grillari, J., & Ogrodnik, M. B. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111588 · Cited by 33
Khan, A. H., Chowers, I., & Lotery, A. J. (2023) · Cells · doi:10.3390/cells12131708 · Cited by 31
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Is cellular senescence involved in cystic fibrosis?
Bezzerri, V., Piacenza, F., Caporelli, N., Malavolta, M., Provinciali, M., & Cipolli, M. (2019) · Respiratory Research · doi:10.1186/s12931-019-0993-2 · Cited by 31
Immunosenescence promotes cancer development: from mechanisms to treatment strategies
Wang, L., & Tang, D. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02082-6 · Cited by 32
Targeting Aging: Lessons Learned From Immunometabolism and Cellular Senescence
Martin, D. E., Torrance, B. L., Haynes, L., & Bartley, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.714742 · Cited by 29
Hoff, U., Markmann, D., Thurn-Valassina, D., Nieminen-Kelhä, M., Erlangga, Z., Schmitz, J., Bräsen, J. H., Budde, K., Melk, A., & Hegner, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266319 · Cited by 30
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
Cai, X., Guillot, A., & Liu, H. (2022) · Cells · doi:10.3390/cells12010132 · Cited by 31
An, Y., Yu, R., Liu, H., Ge, C., & Dang, W. (2023) · GeroScience · doi:10.1007/s11357-023-00863-w · Cited by 30
Sahu, P., & Satapathy, T. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01867-y · Cited by 30
Wang, H., Yu, Y., Li, R., Zhang, H., Chen, Z., Sun, C., & Zhuang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.022 · Cited by 36
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
Martino, S. D., Amoreo, C. A., Nuvoli, B., Galati, R., Strano, S., Facciolo, F., Alessandrini, G., Pass, H. I., Ciliberto, G., Blandino, G., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0044-8 · Cited by 29
Mathot, E., Liberman, K., Dinh, H. C., Njemini, R., & Bautmans, I. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111318 · Cited by 29
Antiaging Vaccines Targeting Senescent Cells
Mendelsohn, A. R., & Larrick, J. W. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0008 · Cited by 29
Cell Senescence and Central Regulators of Immune Response
Lunin, S. M., Novoselova, E. G., Glushkova, O. V., Parfenyuk, S. B., Novoselova, T. V., & Khrenov, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084109 · Cited by 28
Reliable Hallmarks and Biomarkers of Senescent Lymphocytes
Сергеевна, М. Ю., Tereshchenko, V., Bogdanova, D. A., & Александрович, Р. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115653 · Cited by 28
Gil, J., & Withers, D. J. (2016) · Nature · doi:10.1038/nature16875 · Cited by 27
A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal
Mastri, M., Tracz, A., Lee, C. R., Dolan, M., Attwood, K., Christensen, J. G., Liu, S., & Ebos, J. M. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.017 · Cited by 28
Self-citationInflammation and tumor immune escape in response to DNA damage
Nihira, N. T., Kudo, R., & Ohta, T. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.02.005 · Cited by 27
Anti-senescence therapies: a new concept to address cardiovascular disease
Stojanović, S. D., Thum, T., & Bauersachs, J. K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf030 · Cited by 32
The female reproduction and senescence nexus
Marquez, C. M., Ibana, J. A., & Velarde, M. C. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12646 · Cited by 28
DNA Damage and Senescence-Associated Inflammation in Cardiovascular Disease
Ishida, T., Ishida, M., Tashiro, S., & Takeishi, Y. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00865 · Cited by 27
Lim, J. S., Lee, D. Y., Kim, H.-S., Park, S. C., Park, J. T., Kim, H. S., Oh, W. K., & Cho, K. A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111355 · Cited by 28
Cell senescence: basic mechanisms and the need for computational networks in vascular ageing
Regnault, V., Challande, P., Pinet, F., Li, Z., & Lacolley, P. J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa318 · Cited by 27
Liu, S., Jia, X., Hao, J., Zhang, D., Yang, S., Dai, B., Mao, Y., & Li, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301798 · Cited by 27
Self-citationGuo, H., Chen, J., Yu, H., Dong, L., Yu, R., Li, Q., Song, J., Chen, H., Zhang, H., Pu, J., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110864 · Cited by 28
Rolt, A., Nair, A., & Cox, L. S. (2019) · Biogerontology · doi:10.1007/s10522-019-09796-4 · Cited by 29
The dual role of cellular senescence in human tumor progression and therapy
Ma, L., Yu, J., Fu, Y., He, X., Ge, S., Jia, R., Zhuang, A., Yang, Z. H., & Fan, X. (2024) · MedComm · doi:10.1002/mco2.695 · Cited by 30
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression
Amengual, J., Alay, A., Vaquero, J., Gonzalez‐Sanchez, E., Bertrán, E., Sánchez, A., Herrera, B. M., Meyer, K. R., Maus, M., Serrano, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07063-0 · Cited by 27
Ramponi, V., Richart, L., Kovatcheva, M., Attolini, C. S., Capellades, J., Lord, A. E., Yanes, Ó., Ficz, G., & Serrano, M. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0529 · Cited by 29
Zhao, H., Zhang, Y., Ren, Y., & Wang, W. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.13.12 · Cited by 26
Natural Modulators of Key Signaling Pathways in Skin Inflammageing
Ren, Q., Qu, L., Yuan, Y., & Wang, F. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s502252 · Cited by 29
Understanding and targeting senescence in kidney disease
Chanvillard, L., Mason, T., & Ferenbach, D. A. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf190 · Cited by 28
Ma, L., Zhao, W., Zheng, Q., Chen, T., Qi, J., Li, G., & Tong, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.004 · Cited by 26
Rejuvenating Strategies of Tissue-specific Stem Cells for Healthy Aging
Wang, M., Chen, J., Chen, F., Liu, Q., Sun, Y., Chen, Y., Yang, T., Bao, Y., & Hu, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.1119 · Cited by 27
Self-citationDistinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function
Sandri, B. J., Masvidal, L., Murie, C., Bartish, M., Avdulov, S. V., Higgins, L., Markowski, T. W., Peterson, M., Bergh, J. C. S., Yang, P., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201801-0080oc · Cited by 26
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
Mabrouk, N., Ghione, S., Laurens, V., Plenchette, S., Bettaı̈eb, A., & Paul, C. (2020) · Cancers · doi:10.3390/cancers12051145 · Cited by 28
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 27
Dysregulation of leukocyte trafficking in ageing: Causal factors and possible corrective therapies
Hopkin, S. J., Lord, J. M., & Chimen, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105323 · Cited by 27
Autophagy and PTEN in DNA damage-induced senescence
Sharma, A., & Almasan, A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.006 · Cited by 26
Ashimori, A., Nakahata, Y., Sato, T., Fukamizu, Y., Matsui, T., Yoshitane, H., Fukada, Y., Shinohara, K., & Bessho, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.647589 · Cited by 26
Emerging links among Chromosome Instability (CIN), cancer, and aging
Rao, C. V., Asch, A. S., & Yamada, H. Y. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22539 · Cited by 27
Gleyzer, N., & Scarpulla, R. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719682 · Cited by 26
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
Baghdadi, M., Nespital, T., Monzó, C., Deelen, J., Grönke, S., & Partridge, L. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101902 · Cited by 28
Ahmad, A., Braden, A. A., Khan, S., Xiao, J., & Khan, M. M. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01016-7 · Cited by 31
Metabolic reprogramming in cancer and senescence
Zhang, Y., Tang, J., Jiang, C., Yi, H., Shu, G., Yin, G., & Wang, M. (2025) · MedComm · doi:10.1002/mco2.70055 · Cited by 25
The secretome of senescent monocytes predicts age-related clinical outcomes in humans
Olinger, B., Banarjee, R., Dey, A. K., Tsitsipatis, D., Tanaka, T., Ram, A., Nyunt, T., Daya, G. N., Peng, Z., Shrivastava, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00877-3 · Cited by 32
Aging microenvironment in osteoarthritis focusing on early-stage alterations and targeted therapies
Dang, Y., Liu, Y., Zhang, B., & Zhang, X. (2025) · Bone Research · doi:10.1038/s41413-025-00465-6 · Cited by 30
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Niklander, S. E., Lambert, D., & Hunter, K. D. (2021) · Cells · doi:10.3390/cells10123315 · Cited by 28
Senotherapies: A novel strategy for synergistic anti-tumor therapy
Qi, X., Li, J., & Cao, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103365 · Cited by 25
Cellular senescence: when growth stimulation meets cell cycle arrest
Blagosklonny, M. V. (2023) · Aging · doi:10.18632/aging.204543 · Cited by 26
Senescent Stromal Cells in the Tumor Microenvironment: Victims or Accomplices?
Ye, M., Huang, X., Wu, Q., & Liu, F. (2023) · Cancers · doi:10.3390/cancers15071927 · Cited by 27
Su, Y., Wang, P., Shen, H., Sun, Z., Xu, C., Li, G., Tong, T., & Chen, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.207217 · Cited by 24
The origins of cancer cell dormancy
Morales-Valencia, J., & David, G. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101914 · Cited by 25
Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer
He, Y., Qiu, Y., Yang, X., Lu, G., & Zhao, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.11.002 · Cited by 25
Endometrial Aging and Reproductive Decline: The Central Role of Mitochondrial Dysfunction
Kobayashi, H., Nishio, M., Umetani, M., Shigetomi, H., Imanaka, S., & Hashimoto, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115060 · Cited by 28
Measuring the Senescence-Associated Secretory Phenotype
Karras, A., Λιούλιος, Γ., Kantartzi, K. M., Fylaktou, A., Panagoutsos, S. A., & Stangou, M. J. (2025) · Biomedicines · doi:10.3390/biomedicines13092062 · Cited by 27
Gao, D., Kan, P., He, Y., Sun, S., Tang, L., & Yang, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656733 · Cited by 25
Metadata
- Authors
- Laberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., Limbad, C., Demaria, M., Li, P., Hubbard, G. B., Ikeno, Y., Javors, M., Desprez, P.-Y., Benz, C. C., Kapahi, P., Nelson, P. S., & Campisi, J.
- Affiliations
- Chinese Academy of Sciences (CN)
- Buck Institute for Research on Aging (US)
- The University of Texas at San Antonio Health Science Center (US)
- Fred Hutch Cancer Center (US)
- Corresponding author
- Campisi, Judith
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-07-06
- Volume
- 17
- Issue
- 8
- Pages
- 1049-1061
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4691706
- OpenAlex
- W1033197108
- Cited by
- 1,160
- References
- 72
- Citations by year
- 2026: 119 · 2025: 114 · 2024: 109 · 2023: 99 · 2022: 137 · 2021: 122 · 2020: 112 · 2019: 87 · 2018: 89 · 2017: 78 · 2016: 72 · 2015: 22
- FWCI
- 64.11
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-04-06)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG041122, R56AG009909, AG017242, AG-09909, RL1AG032113, AG045288, P01AG025901, R01AG045835, R37AG009909, P01AG041122, K99AG045288, AG032113, P01AG017242, AG000266-16, AG025901, P30AG013319, P30AG044271, T32AG000266)
- National Cancer Institute (CA097186, CA155679, R21CA155679, U24CA143858, CA165573, R01CA165573, CA071468, CA164188, R01CA071468, CA143858, U01CA164188, P50CA097186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- mTOR, TORC1, rapamycin, senescence-associated secretory phenotype, cellular senescence, interleukin-6, NF-κB, senescence-associated inflammation, age-related cancer, longevity, translational regulation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Antineoplastic Agents, Dose-Response Relationship, Drug, Fibroblasts, Humans, Male, Mitoxantrone, Phenotype, Prostatic Neoplasms, RNA, Messenger, Time Factors, Transcription, Genetic, Transfection, Interleukin-6, Up-Regulation, Gene Expression Regulation, Neoplastic, NF-kappa B, Mice, SCID, Cellular Senescence, Inflammation Mediators, Sirolimus, Xenograft Model Antitumor Assays, RNA Interference, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Interleukin-1alpha, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
